Theravance Biopharma Cash from Operations (TTM) Trends

Theravance Biopharma Inc (TBPH)

9.112 -0.03 (-0.31%) USD | NASDAQ | Apr 26, 16:00

9.112 0.00 (0.00%) After-Hours: 18:48

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	-27.00M
September 30, 2023	-150.20M
June 30, 2023	-169.85M
March 31, 2023	-172.14M
December 31, 2022	-186.99M
September 30, 2022	-105.37M
June 30, 2022	-128.68M
March 31, 2022	-164.06M
December 31, 2021	-207.86M
September 30, 2021	-230.35M
June 30, 2021	-261.93M
March 31, 2021	-265.17M
December 31, 2020	-250.40M
September 30, 2020	-249.83M
June 30, 2020	-217.42M
March 31, 2020	-212.10M
December 31, 2019	-238.20M
September 30, 2019	-226.02M
June 30, 2019	-230.38M
March 31, 2019	-243.88M
December 31, 2018	-112.87M

Date	Value
September 30, 2018	-104.89M
June 30, 2018	-118.21M
March 31, 2018	-101.20M
December 31, 2017	-201.05M
September 30, 2017	-184.96M
June 30, 2017	-135.10M
March 31, 2017	-122.71M
December 31, 2016	-98.99M
September 30, 2016	-104.62M
June 30, 2016	-124.17M
March 31, 2016	-138.65M
December 31, 2015	-168.86M
September 30, 2015	-177.65M
June 30, 2015	-182.04M
March 31, 2015	-186.87M
December 31, 2014	-175.16M
September 30, 2014	-167.80M
June 30, 2014	-164.36M
March 31, 2014	-137.27M
December 31, 2013	-120.96M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-265.17M

Minimum

Mar 2021

-27.00M

Maximum

Dec 2023

-194.42M

Average

-212.10M

Median

Mar 2020

Cash from Operations (TTM) Benchmarks